Related Experiment Video
Updated: May 8, 2025

10:33
Generation of Alginate Microspheres for Biomedical Applications
Published on: August 12, 2012
20.6K
Microencapsulation of Liver Spheroids with Poly(Vinyl Alcohol) Enhances Function Compared with Alginate
Stephen Harrington1, Edward Larson1, Aldyn Wildey1
1Likarda Inc, Kansas City, Missouri, USA.
Tissue Engineering. Part A
|April 22, 2025
Summary
Poly(vinyl alcohol) (PVA) microcapsules improve liver spheroid transplantation outcomes compared to alginate. PVA encapsulation enhances cell viability, function, and albumin secretion in vivo, offering a promising strategy for chronic liver disease therapy.
Area of Science:
- Biomaterials Science
- Hepatology
- Regenerative Medicine
Background:
- Cell therapy for chronic liver disease offers limited success due to rapid cell loss post-transplantation.
- Alginate microencapsulation protects cells but suffers from poor biocompatibility, leading to graft failure.
- Developing biocompatible microencapsulation materials is crucial for improving cell transplantation efficacy.
Purpose of the Study:
- To evaluate poly(vinyl alcohol) (PVA) microcapsules as a biocompatible alternative to alginate for encapsulating liver spheroids.
- To compare the viability, function, and in vivo performance of PVA-encapsulated liver spheroids against alginate-encapsulated and unencapsulated controls.
Main Methods:
- Human hepatocyte spheroids were encapsulated in alginate or PVA hydrogel microspheres.
- In vitro assessment of spheroid viability, albumin secretion, and CYP activity at 3, 10, and 30 days.
- In vivo transplantation into immunodeficient mice to monitor serum albumin levels and biocompatibility in immune-competent mice.
Main Results:
- PVA-encapsulated spheroids exhibited significantly higher CYP1A1 induction, albumin secretion, and metabolic activity at day 30 compared to alginate.
- Mice receiving PVA spheroids showed higher serum albumin levels post-transplantation than those receiving alginate or unencapsulated spheroids.
- PVA microspheres demonstrated reduced foreign body response in vivo compared to alginate, which induced significant inflammation.
Conclusions:
- PVA-based microencapsulation significantly enhances the viability, metabolic activity, and function of transplanted liver spheroids compared to alginate.
- PVA microencapsulation offers a superior biocompatible platform for liver spheroid transplantation, improving therapeutic outcomes in chronic liver disease models.
- Both alginate and PVA encapsulation improved outcomes over unencapsulated cells, but PVA demonstrated clear advantages in long-term function and biocompatibility.

